scholarly journals Central modules of the vaccinia virus complement control protein are not in extensive contact

1999 ◽  
Vol 344 (1) ◽  
pp. 167-175 ◽  
Author(s):  
Marina D. KIRKITADZE ◽  
Colin HENDERSON ◽  
Nicholas C. PRICE ◽  
Sharon M. KELLY ◽  
Nicholas P. MULLIN ◽  
...  

The 28.6 kDa vaccinia virus complement control protein (VCP) is an inhibitor of the complement system and has therapeutic potential. It is composed of four domains or modules and is a homologue of complement receptor 1 (CR1) and other mammalian regulators of complement activation. A key aspect to structure-function relationships in these proteins is the extent of intramolecular module-module interactions, since these dictate the overall shape and flexibility of the molecules. A protein fragment (VCP∼ 2,3) encompassing modules 2 and 3 of VCP was over-expressed in Pichia pastoris. Ultracentrifugation showed that VCP∼ 2,3 is highly asymmetric with an axial ratio of 5.3:1, which is consistent with an end-to-end arrangement of the two modules. NMR spectroscopy, differential scanning calorimetry, CD and intrinsic tryptophan fluorescence were used to monitor unfolding of VCP∼ 2,3. Experiments performed over a range of temperatures and concentrations of guanidinium chloride revealed that module 2 unfolds under milder conditions than, and independently of, module 3. Unfolding of module 2 is not associated with extensive changes in amide 15N and 1H chemical shifts of module 3, implying that the modules do not form an extensive intermodular interface. Results obtained in this work for VCP∼ 2,3 are compared with those obtained in a study of CR1 modules 15-17 [Kirkitadze, Krych, Uhrin, Dryden, Smith, Cooper, Wang, Hauhart, Atkinson and Barlow (1999) Biochemistry 38, 7019-7031].

Vaccine ◽  
2011 ◽  
Vol 29 (43) ◽  
pp. 7435-7443 ◽  
Author(s):  
John Bernet ◽  
Muzammil Ahmad ◽  
Jayati Mullick ◽  
Yogesh Panse ◽  
Akhilesh K. Singh ◽  
...  

2009 ◽  
Vol 90 (11) ◽  
pp. 2604-2608 ◽  
Author(s):  
Joan E. Adamo ◽  
Clement A. Meseda ◽  
Jerry P. Weir ◽  
Michael J. Merchlinsky

Vaccination with Dryvax elicits a broad humoral response against many viral proteins. Human vaccinia immune globulin was used to screen the secreted proteins from cells infected with Dryvax or the candidate smallpox vaccine LC16m8 to determine whether the protective humoral response included antibodies against secreted viral proteins. Many proteins were detected, with the primary band corresponding to a band of 28 or 30 kDa in cells infected with Dryvax or LC16m8, respectively. This was identified as the vaccinia virus complement protein (VCP), which migrated more slowly in LC16m8-infected cells due to post-translational glycosylation. Vaccinia virus deleted in VCP, vVCPko, protected mice from a lethal intranasal challenge of vaccinia Western Reserve strain. Mice vaccinated with purified VCP demonstrated a strong humoral response, but were not protected against a moderate lethal challenge of vaccinia virus, suggesting that the humoral response against VCP is not critical for protection.


2002 ◽  
Vol 34 (8) ◽  
pp. 3277-3281 ◽  
Author(s):  
J.B Anderson ◽  
S.A Smith ◽  
R van Wijk ◽  
S Chien ◽  
G.J Kotwal

Sign in / Sign up

Export Citation Format

Share Document